To confirm whether RORA inhibited the migration, invasion, and EMT of GBM via negatively affecting the TGF-β1/Smad signaling pathway, the RORA-overexpressed GSC4D was treated with human recombinant TGF-β1. Here, RORA is linked to glioblastoma.